Monday, February 25, 2013

Neupro - First Transdermal patch for Parkinson and Restless Leg Syndrome launched in Japan

Otsuka Pharmaceutical Co., Ltd. today announced the launch of Neupro® Patch (chemical name: rotigotine) indicated for both the treatment of Parkinson’s disease and Restless Legs Syndrome*2 in Japan, on February 26, 2013.
Neupro® Patch is the only transdermal dopamine agonist system available in the world, which only needs to be applied once a day, enabling a clinically-effective blood drug concentration via stable drug delivery throughout a 24-hour period.

There are estimated to be approximately 140,000 Parkinson’s disease patients in Japan, and the number of patients is rising with the aging society








Enter your email address:


Delivered by FeedBurner